Initial laboratory data from 2013
| Variable | Patient's result | Normal value |
| WBC count cells·mm−3 | 11 100 | 4000–11 000 |
| Neutrophil count % of WBC | 73 | 40–75 |
| Lymphocyte count % of WBC | 20 | 20–40 |
| Monocyte count % of WBC | 4 | 2–10 |
| Eosinophil count % of WBC | 3 | 1–5 |
| Basophil count % of WBC | 0 | 0–1 |
| Haemoglobin g·dL−1 | 13 | 12–14 |
| Haematocrit % | 38.3 | 36–42 |
| Platelet count cells·mm−3 | 210 000 | 140 000–440 000 |
| International normalised ratio | 1.1 | <1.0 |
| Urea nitrogen mg·dL−1 | 17 | 6–30 |
| Creatinine mg·dL−1 | 0.80 | 0.5–1.0 |
| Creatine kinase units·L−1 | 83 | 30–135 |
| Alanine transaminase units·L−1 | 26 | 9–52 |
| Aspartate transaminase units·L−1 | 28 | 5–40 |
| Urine analysis | Normal | |
| ESR mm·h−1 | 43 | 0–30 |
| C-reactive protein mg·dL−1 | 2.95 | <0.748 |
| Anti-nuclear antibody | 2.21 | <1:40 |
| Rheumatoid factor units·mL−1 | 30 | <14 |
| Anti-cyclic citrullinated protein antibody units·mL−1 | 0.50 | <5 |
| Angiotensin converting enzyme units·L−1 | 86.5 | 20–70 |
| Anti-MPO antibody | 99.4 | <10 |
| Anti–SSa antibody | 7.2 | <20 |
| Anti-Scl-70 antibody | 2.79 | <20 |
| Anti-dsDNA units·mL−1 | 29.59 | <30 |
| Anti-proteinase 3 antibody | 4.04 | <10 |
| Anti–Jo-1 antibody | 0.48 | <3 |
| Anti-Smith antibody | 6.83 | <20 |
| C3 complement mg·dL−1 | 156.38 | 90–180 |
| C4 complement mg·dL−1 | 38.25 | 10–40 |
WBC: white blood cell.